Association of transforming growth factor-β1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases

Haematologica

Volumn 92, Issue 11, 2007, Pages 1470-1474

  Hatta, Kanako ^a   Morimoto, Akira ^a   Ishii, Eiichi ^b   Kimura, Hiroshi ^c   Ueda, Ikuyo ^a   Hibi, Shigeyoshi ^a   Todo, Shinjiro ^a   Sugimoto, Tohru ^a   Imashuku, Shinsaku ^d  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Takasago seibu Hospital   (Japan)

Author keywords

Cytokine gene polymorphism; Epstein Barr virus; IL 1; TGF 1

Indexed keywords

CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CODON; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEMATOLOGIC DISEASE; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HERPES VIRUS INFECTION; HUMAN; INFANT; INFECTIOUS MONONUCLEOSIS; MAJOR CLINICAL STUDY; MALE; NEWBORN; POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CODON; CYTOKINES; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMATOLOGIC DISEASES; HUMANS; IMMUNITY; INFANT; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA1;

EID: 36349023815     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11147     Document Type: Article

References (37)

1. Seeley J, Svedmyr E, Weiland O, Klein G, Moller E, Eriksson E, et al. Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens. J Immunol 1981;127:293-300.
2. Kasahara Y, Yachie A. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol Hematol 2002;44:283-94.
3. Linde A, Andersson B, Svenson SB, Ahme H, Carlsson M, Forsberg P, et al. Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J Infect Dis 1992;165:994-1000.
4. Hornef MW, Wagner HJ, Kruse A, Kirchner H. Cytokine production in a whole-blood assay after Epstein-Barr virus infection in vivo. Clin Diagn Lab Immunol 1995;2:209-13.
5. Imashuku S, Hibi S, Tabata Y, Sako M, Sekine Y, Hirayama K, et al. Biomarker and morphological characteristics of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1998; 31:131-7.
6. Imashuku S. Advances in the management of hemophagocytic lymphohistiocytosis. Int J Hematol 2000;72:1-11.
7. Kanegane H, Wakiguchi H, Kanegane C, Kurashige T, Tosato G. Viral interleukin-10 in chronic active Epstein-Barr virus infection. J Infect Dis 1997;176:254-7.
8. Helminen ME, Kilpinen S, Virta M, Hurme M. Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis 2001;184:777-80.
9. Hurme M, Helminen M. Polymorphism of the IL-1 gene complex in Epstein-Barr virus seronegative and seropositive adult blood donors. Scand J Immunol 1998;48: 219-22.
10. Dierksheide JE, Baiocchi RA, Ferketich AK, Roychowdhury S, Pelletier RP, Eisenbeis CF, et al. IFN-gamma gene polymorphisms associated with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice. Blood 2005;105: 1558-65.
11. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associatecf hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 2002;44:259-72.
12. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991;18:29-33.
13. Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 2005;80: 64-9.
14. Wahl SM, Wen J, Moutsopoulos N. TGF-β: a mobile purveyor of immune privilege. Immunol Rev 2006;213:213-27.
15. Blomhoff HK, Smeland E, Mustafa AS, Godal T, Ohlsson R. Epstein-Barr virus mediates a switch in responsiveness to transforming growth factor, type β, in cells of the B cell lineage. Eur J Immunol 1987; 17:299-301.
16. Andersson J. Clinical and immunological considerations in Epstein-Barr virus-associated diseases. Scand J Infect Dis Suppl 1996;100:72-82.
17. Xu J, Menezes J, Prasad U, Ahmad A. Elevated serum levels of transforming growth factor β1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients. Int J Cancer 1999;84:396-9.
18. Ohga S, Nomura A, Takada H, Tanaka T, Furuno K, Takahata Y, et al. Dominant expression of interleukin-10 and transforming growth factor-β genes in activated T-cells of chronic active Epstein-Barr virus infection. J Med Virol 2004;74:449-58.
19. Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, et al. Transforming growth factor-β 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA 2000;97:3479-84.
20. Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, et al. Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 1998;13:1569-76.
21. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;15:1627-52.
22. Foss HD, Herbst, H, Hummel M, Araujo I, Latza U, Rancso C, et al. Patterns of cytokine gene expression in infectious mononucleosis. Blood 1994;83:707-12.
23. Henter JI, Andersson B, Elinder G, Jakobson A, Lubeck PO, Soder O. Elevated circulating levels of interleukin-1 receptor antagonist but not IL-1 agonists in hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1996;27: 21-5.
24. Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1993;15:92-8.
25. Ishii E, Ohga S, Aoki T, Yamada S, Sako M, Tasaka H, et al. Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor. Acta Haematol 1991;85: 93-9.
26. Shirodaria S, Smith J, McKay IJ, Kennett CN, Hughes FJ. Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1α protein in gingival crevicular fluid of teeth with severe periodontal disease. J Dent Res 2000;79:1864-9.
27. Dominici R, Cattaneo M, Malferrari G, Archi D, Mariani C, Grimaldi LM, et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 α. Immunogenetics 2002;54:82-6.
28. Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, et al. Polymorphisms of the transforming growth factor-β1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 1996;28:881-7.
29. Wu L, Chau J, Young RP, Pokorny V, Mills GD, Hopkins R, et al. Transforming growth factor-β1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 2004;59:126-9.
30. Ravindran JS, Owen P, Lagan A, Lewis J, Korendowych E, Welsh K, et al. Interleukin 1α, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis. Rheumatology 2004;43:22-6.
31. Um JY, Moon KS, Lee KM, Yun JM, Cho KH, Moon BS, et al. Association of interleukin-1 α gene polymorphism with cerebral infarction. Mol Brain Res 2003; 115:50-4.
32. Cinek O, Vavrincova P, Striz I, Drevinek P, Sedlakova P, Vavrinec J, et al. Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. J Rheumatol 2004;31:1206-10.
33. Bugunia-Kubic K, Mlynarczewska A, Jaskula E, Lange A. The presence of IFNG 3/3 genotype in the recipient associates with increased risk for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2005; 132: 326-32.
34. Teramura T, Tabata Y, Yagi T, Morimoto A, Hibi S, Imashuku S. Quantitative analysis of cell-free Epstein-Barr virus genome copy number in patients with EBV-associated hemophagocytic lymphohistiocytosis. Leuk Lymphoma 2002;43: 173-9.
35. Kimura H, Hoshino Y, Hara S, Nishikawa K, Sako M, Hirayama M, et al. Viral load in Epstein-Barr virus-associated hemophagocytic syndrome. Microbiol Immunol 2002; 46:579-82.
36. Zaitsu M, Yamamoto K, Ishii E, Teramura T, Nakadate N, Sako M, et al. High frequency of QPY allele and linkage disequilibrium of granzyme-B in Epstein-Barr-virus-associated hemophagocytic lymphohistiocytosis. Tissue Antigens 2004;64: 611-5.
37. Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Review Med Virol 2006; 16:251-61.